Home   |    Site Map   |    Copyright   |    Contact us   |    Privacy   |   
enzyme (lysozyme)

 
Enzymes
  Enzyme classes:
  EC 1: Oxidoreductases
  EC 2: Transferases
    EC 2.1
    EC 2.2
    EC 2.3
    EC 2.4
    EC 2.5
    EC 2.6
    EC 2.7
      EC 2.7.1
      EC 2.7.2
      EC 2.7.3
      EC 2.7.4
      EC 2.7.5
      EC 2.7.6
      EC 2.7.7
      EC 2.7.8
      EC 2.7.9
      EC 2.7.10
      EC 2.7.11
        EC 2.7.11.1
        EC 2.7.11.2
        EC 2.7.11.3
        EC 2.7.11.4
        EC 2.7.11.6
        EC 2.7.11.7
        EC 2.7.11.8
        EC 2.7.11.9
        EC 2.7.11.10
        EC 2.7.11.11
        EC 2.7.11.12
        EC 2.7.11.13
        EC 2.7.11.14
        EC 2.7.11.15
        EC 2.7.11.16
        EC 2.7.11.17
        EC 2.7.11.18
        EC 2.7.11.19
        EC 2.7.11.20
        EC 2.7.11.21
        EC 2.7.11.22
        EC 2.7.11.23
        EC 2.7.11.24
        EC 2.7.11.25
        EC 2.7.11.26
        EC 2.7.11.27
        EC 2.7.11.28
        EC 2.7.11.29
        EC 2.7.11.30
        EC 2.7.11.31
      EC 2.7.12
      EC 2.7.13
      EC 2.7.14
    EC 2.8
    EC 2.9
  EC 3: Hydrolases
  EC 4: Lyases
  EC 5: Isomerases
  EC 6: Ligases
  General information:
  Catalytic mechanism
  Enzyme kinetics
  Inhibitors
  Enzymes in industry

EC 2.7.11.30 - ATP:[receptor- protein] phosphotransferase (receptor protein serine/threonine kinase)



3D structures of EC 2.7.11.30 - receptor protein serine/threonine kinase in Protein Data Bank

updated: 6 January 2022, 2:15

In total: 139 PDB structures of EC 2.7.11.30 - receptor protein serine/threonine kinase:
  1. 3oom: Crystal Structure of The Acvr1 Kinase Domain in Complex with The Imidazo[1,2-b]pyridazine Inhibitor K00507
  2. 3nh7: Crystal Structure of The Neutralizing Fab Fragment Abd1556 Bound to The Bmp Type I Receptor Ia
  3. 3my0: Crystal Structure of The Acvrl1 (alk1) Kinase Domain Bound to Ldn- 193189
  4. 3mtf: Crystal Structure of The Acvr1 Kinase in Complex with a 2- Aminopyridine Inhibitor
  5. 3mdy: Crystal Structure of The Cytoplasmic Domain of The Bone Morphogenetic Protein Receptor Type-1b (BMPR1B) in Complex with Fkbp12 and Ldn- 193189
  6. 3kcf: Crystal Structure of Tgfbri Complexed with a Pyrazolone Inhibitor
  7. 3hmm: Structure of Alk5 + Gw855857
  8. 3h9r: Crystal Structure of The Kinase Domain of Type I Activin Receptor (acvr1) in Complex with Fkbp12 and Dorsomorphin
  9. 3gxl: Alk-5 Kinase Complex with Gw857175
  10. 3g2f: Crystal Structure of The Kinase Domain of Bone Morphogenetic Protein Receptor Type II (bmpr2) at 2.35 a Resolution
  11. 3faa: Crystal Structure of Tgfbri Complexed with a 2- Aminoimidazole Inhibitor
  12. 2x7o: Crystal Structure of Tgfbri Complexed with an Indolinone Inhibitor
  13. 2wou: Alk5 in Complex with 4-((4-((2,6-dimethyl-3-pyridyl)oxy)-2- Pyridyl)amino)benzenesulfonamide
  14. 2wot: Alk5 in Complex with 4-((5,6-dimethyl-2-(2-pyridyl)-3- Pyridyl)oxy)-n-(3,4,5-trimethoxyphenyl)pyridin-2-amine
  15. 7a21: Crystal Structure of The Acvr1 (alk2) Kinase in Complex with The Compound M4K2158
  16. 6zgc: Crystal Structure of The Acvr1 (alk2) Kinase in Complex with The Compound Saracatinib (azd0530)
  17. 2qlu: Crystal Structure of Activin Receptor Type II Kinase Domain from Human
  18. 2pjy: Structural Basis for Cooperative Assembly of The Tgf-beta Signaling Complex
  19. 6b8y: Tgf-beta Receptor Type 1 Kinase Domain (T204D) in Complex with N-(3- Fluoropyridin-4-yl)-2-[6-(trifluoromethyl)pyridin-2-yl]-7h-pyrrolo[2, 3-d]pyrimidin-4-amine
  20. 6acr: Crystal Structure of Human Alk2 Kinase Domain with R206H Mutation in Complex with Rk-59638
  21. 2goo: Ternary Complex of Bmp-2 Bound to Bmpr-ia-ecd and Actrii-ecd
  22. 2h62: Crystal Structure of a Ternary Ligand-receptor Complex of Bmp-2
  23. 2h64: Crystal Structure of a Ternary Ligand-receptor Complex of Bmp-2
  24. 6tn8: Crystal Structure of The Acvr1 (alk2) Kinase in Complex with The Compound Bi-9564
  25. 2hlq: Crystal Structure of The Extracellular Domain of The Type II Bmp Receptor
  26. 2hlr: Crystal Structure of The Extracellular Domain of The Type II Bmp Receptor
  27. 2k3g: Nmr Structure Analysis of a Bmp Receptor
  28. 6z36: Crystal Structure of The Acvr1 (alk2) Kinase in Complex with The Compound M4K2118
  29. 3q4t: Crystal Structure of Activin Receptor Type-iia (ACVR2A) Kinase Domain in Complex with Dorsomorphin
  30. 3q4u: Crystal Structure of The Acvr1 Kinase Domain in Complex with Ldn- 193189
  31. 6jux: Crystal Structure of Human Alk2 Kinase Domain with R206H Mutation in Complex with Rk-71807
  32. 6sf3: Bone Morphogenetic Protein 10 (bmp10) in Complex with Extracellular Domain of Activin Receptor-like Kinase 1 (alk1) at 2.3 Angstrom
  33. 6sf2: Ternary Complex of Human Bone Morphogenetic Protein 9 (bmp9) Growth Factor Domain, Its Prodomain and Extracellular Domain of Activin Receptor-like Kinase 1 (alk1).
  34. 6sf1: Bone Morphogenetic Protein 10 (bmp10) Complexed with Extracellular Domain of Activin Receptor-like Kinase 1 (alk1).
  35. 3soc: Crystal Structure of Activin Receptor Type-iia (ACVR2A) Kinase Domain in Complex with a Quinazolin
  36. 6t8n: Crystal Structure of The Acvr1 (alk2) Kinase in Complex with The Compound M4K3007
  37. 6t6d: Crystal Structure of The Acvr1 (alk2) Kinase in Complex with The Compound M4K2149
  38. 6szm: Crystal Structure of The Acvr1 (alk2) Kinase in Complex with The Compound M4K2009
  39. 6srh: Crystal Structure of The Acvr1 (alk2) Kinase in Complex with The Compound M4K2117
  40. 2l5s: Solution Structure of The Extracellular Domain of The Tgf-beta Type I Receptor
  41. 3qb4: Crystal Structure of a Tgf-beta Ligand-receptor Complex
  42. 4dym: Crystal Structure of The Acvr1 Kinase Domain in Complex with The Imidazo[1,2-b]pyridazine Inhibitor K00135
  43. 3tzm: Tgf-beta Receptor Type 1 in Complex with Sb431542
  44. 4asx: Crystal Structure of Activin Receptor Type-iia (ACVR2A) Kinase Domain in Complex with Dihydro-bauerine C
  45. 2lcr: Nmr Structure of Alk1 Extracellular Domain
  46. 6mac: Ternary Structure of Gdf11 Bound to Actriib-ecd and Alk5-ecd
  47. 6i1s: Crystal Structure of The Acvr1 (alk2) Kinase in Complex with Fkbp12 and The Inhibitor E6201
  48. 4bgg: Crystal Structure of The Acvr1 Kinase in Complex with Ldn-213844
  49. 6gip: Crystal Structure of The Acvr1 (alk2) Kinase in Complex with a Quinazolinone Based Alk2 Inhibitor with a 2, 5-dimethyl Core.
  50. 6gin: Crystal Structure of The Acvr1 (alk2) Kinase in Complex with an Quinazolinone Based Alk2 Inhibitor with a 4-morpholinophenyl Solvent Accessible Group.
  51. 6gi6: Crystal Structure of The Acvr1 (alk2) Kinase in Complex with a Quinazolinone Based Alk2 Inhibitor with a 5-methyl Core.
  52. 6eix: Crystal Structure of The Kinase Domain of The Q207E Mutant of Acvr1 (alk2) in Complex with a 2-aminopyridine Inhibitor K02288
  53. 4c02: Crystal Structure of Human Acvr1 (alk2) in Complex with Fkbp12.6 and Dorsomorphin
  54. 5qtz: Tgf-beta Receptor Type 1 Kinase Domain (T204D) in Complex with 6-[1- (2,2-difluoroethyl)-4-(6-methylpyridin-2-yl)-1h-imidazol-5- Yl]imidazo[1,2-a]pyridine
  55. 5qu0: Tgf-beta Receptor Type 1 Kinase Domain (T204D) in Complex with 6-[4- (3-chloro-4-fluorophenyl)-1-(2-hydroxyethyl)-1h-imidazol-5- Yl]imidazo[1,2-b]pyridazine-3-carbonitrile
  56. 5usq: Alk-5 Kinase Inhibitor Complex
  57. 5ty4: Microed Structure of a Complex between Monomeric Tgf-b and Its Receptor, Tbrii, at 2.9 a Resolution
  58. 5tx4: Derivative of Mouse Tgf-beta2, with a Deletion of Residues 52-71 and K25R, R26K, L51R, A74K, C77S, L89V, I92V, K94R T95K, I98V Single Amino Acid Substitutions, Bound to Human Tgf-beta Type II Receptor Ectodomain Residues 15-130
  59. 5qin: Tgf-beta Receptor Type 2 Kinase Domain in Complex with N- {4-[3-(6- Methoxypyridin-3-yl)-1h-pyrrolo[3,2-b]pyridin-2- Yl]pyridin-2- Yl}acetamide
  60. 5qim: Tgf-beta Receptor Type 1 Kinase Domain (T204D) in Complex with N-{4- [3-(5-methoxypyridin-2-yl)-1h-pyrrolo[3,2-b] Pyridin-2-yl]pyridin-2- Yl}acetamide
  61. 5qil: Tgf-beta Receptor Type 1 Kinase Domain (T204D) in Complex with N-{4- [3-(6-methoxypyridin-3-yl)-1h-pyrrolo[3,2-b]pyridin-2-yl]pyridin-2- Yl}acetamide
  62. 5qik: Tgf-beta Receptor Type 1 Kinase Domain (T204D) in Complex with N-{4- [3-(6-fluoropyridin-3-yl)-4-oxo-4,5,6,7-tetrahydro-1h-pyrrolo[3,2- C]pyridin-2-yl]pyridin-2-yl}acetamide
  63. 5oy6: Crystal Structure of The Acvr1 (alk2) Kinase in Complex with Cyclical Inhibitor Od36.
  64. 5oxg: Crystal Structure of The Acvr1 (alk2) Kinase in Complex with Ldn- 212854
  65. 5nhr: Crystal Structure of The Activin Receptor Type-2b Ligand Binding Domain in Complex with Bimagrumab Fv, Cubic Crystal Form
  66. 5nh3: Crystal Structure of The Activin Receptor Type-2a Ligand Binding Domain in Complex with Bimagrumab Fv
  67. 5ngv: Crystal Structure of The Activin Receptor Type-2b Ligand Binding Domain in Complex with Bimagrumab Fv, Orthorhombic Crystal Form
  68. 5fri: Alk5 in Complex Witha an N-(4-anilino-2-pyridyl)acetamide Inhibitor.
  69. 5e92: Tgf-beta Receptor Type 2 Kinase Domain (E431A,R433A,E485A,K488A,R493A, R495A) in Complex with Amppnp
  70. 5e91: Tgf-beta Receptor Type 2 Kinase Domain (E431A,R433A,E485A,K488A,R493A, R495A) in Complex with 3-amino-6-[4-(2- Hydroxyethyl)phenyl]-n-[4- (morpholin-4-yl)pyridin-3-yl] Pyrazine-2-carboxamide
  71. 5e90: Tgf-beta Receptor Type 1 Kinase Domain (T204D,I211V,Y249F, S280T, Y282F,S287N,A350C,L352F) in Complex with 3-amino-6- [4-(2- Hydroxyethyl)phenyl]-n-[4-(morpholin-4-yl)pyridin-3-yl]pyrazine-2- Carboxamide
  72. 5e8z: Tgf-beta Receptor Type 1 Kinase Domain (T204D) in Complex with 3- Amino-6-[4-(2-hydroxyethyl)phenyl]-n-[4-(morpholin-4-yl)pyridin-3- Yl]pyrazine-2-carboxamide
  73. 5e8y: Tgf-beta Receptor Type 2 Kinase Domain (E431A,R433A,E485A,K488A,R493A, R495A) in Complex with Staurosporine
  74. 5e8x: Tgf-beta Receptor Type 1 Kinase Domain (T204D,I211V,Y249F,S280T, Y282F,S287N,A350C,L352F) in Complex with Staurosporine
  75. 5e8w: Tgf-beta Receptor Type 1 Kinase Domain (T204D) in Complex with Staurosporine
  76. 5e8v: Tgf-beta Receptor Type 2 Kinase Domain (E431A,R433A,E485A,K488A,R493A, R495A)
  77. 5e8u: Tgf-beta Receptor Type 1 Kinase Domain (T204D,I211V,Y249F,S280T, Y282F,S287N,A350C,L352F)
  78. 5e8t: Tgf-beta Receptor Type 1 Kinase Domain (T204D)
  79. 5e8s: Tgf-beta Receptor Type 1 Kinase Domain (wt)
  80. 4x0m: Selection of Fragments for Kinase Inhibitor Design: Decoration Is Key
  81. 4x2j: Selection of Fragments for Kinase Inhibitor Design: Decoration Is Key
  82. 4x2k: Selection of Fragments for Kinase Inhibitor Design: Decoration Is Key
  83. 4x2n: Selection of Fragments for Kinase Inhibitor Design: Decoration Is Key
  84. 4p7u: Extracellular Domain of Type II Transforming Growth Factor Beta Receptor in Complex with Ndsb-201
  85. 4x2f: Selection of Fragments for Kinase Inhibitor Design: Decoration Is Key
  86. 4x2g: Selection of Fragments for Kinase Inhibitor Design: Decoration Is Key
  87. 4xjj: Extracellular Domain of Type II Transforming Growth Factor Beta Receptor in Complex with 2-(2-hydroxyethyl)ndsb-201
  88. 5s75: Xchem Group Deposition -- Crystal Structure of Human Acvr1 in Complex with FM010913A
  89. 7c3g: Crystal Structure of Human Alk2 Kinase Domain with R206H Mutation in Complex with a Bicyclic Pyrazole Inhibitor Rk-73134
  90. 7nns: Crystal Structure of The Acvr1 (alk2) Kinase in Complex with The Compound Momelotinib
  91. 7dv6: Discovery of Functionally Selective Transforming Growth Factor Beta Type II Receptor (tgf-beta Rii) Inhibitors as Anti-fibrosis Agents
  92. 5s76: Xchem Group Deposition -- Crystal Structure of Human Acvr1 in Complex with FM010916A
  93. 5s77: Xchem Group Deposition -- Crystal Structure of Human Acvr1 in Complex with XS035133B
  94. 5s78: Xchem Group Deposition -- Crystal Structure of Human Acvr1 in Complex with FM010934A
  95. 5s79: Xchem Group Deposition -- Crystal Structure of Human Acvr1 in Complex with FM010910A
  96. 5s7a: Xchem Group Deposition -- Crystal Structure of Human Acvr1 in Complex with PK012456B
  97. 5s7b: Xchem Group Deposition -- Crystal Structure of Human Acvr1 in Complex with FM000329D
  98. 5s7c: Xchem Group Deposition -- Crystal Structure of Human Acvr1 in Complex with FM000274C
  99. 5s7d: Xchem Group Deposition -- Crystal Structure of Human Acvr1 in Complex with FM010923A
  100. 5s7e: Xchem Group Deposition -- Crystal Structure of Human Acvr1 in Complex with FM010930A
  101. 5s7f: Xchem Group Deposition -- Crystal Structure of Human Acvr1 in Complex with FM010935A
  102. 5s7g: Xchem Group Deposition -- Crystal Structure of Human Acvr1 in Complex with XS035844B
  103. 5s7h: Xchem Group Deposition -- Crystal Structure of Human Acvr1 in Complex with FM010914A
  104. 5s7i: Xchem Group Deposition -- Crystal Structure of Human Acvr1 in Complex with FM010928A
  105. 5s7j: Xchem Group Deposition -- Crystal Structure of Human Acvr1 in Complex with FM000893D
  106. 5s7k: Xchem Group Deposition -- Crystal Structure of Human Acvr1 in Complex with FM010936A
  107. 5s7l: Xchem Group Deposition -- Crystal Structure of Human Acvr1 in Complex with FM010943A
  108. 5s7m: Xchem Group Deposition -- Crystal Structure of Human Acvr1 in Complex with FM000275D
  109. 5s7n: Xchem Group Deposition -- Crystal Structure of Human Acvr1 in Complex with FM010920A
  110. 5s7o: Xchem Group Deposition -- Crystal Structure of Human Acvr1 in Complex with FM007391C
  111. 5s7p: Xchem Group Deposition -- Crystal Structure of Human Acvr1 in Complex with FM010937A
  112. 5s7q: Xchem Group Deposition -- Crystal Structure of Human Acvr1 in Complex with FM010944A
  113. 5s7r: Xchem Group Deposition -- Crystal Structure of Human Acvr1 in Complex with FM010918A
  114. 5s7s: Xchem Group Deposition -- Crystal Structure of Human Acvr1 in Complex with FM010921A
  115. 5s7t: Xchem Group Deposition -- Crystal Structure of Human Acvr1 in Complex with FM010926A
  116. 5s7u: Xchem Group Deposition -- Crystal Structure of Human Acvr1 in Complex with FM010938A
  117. 5s7v: Xchem Group Deposition -- Crystal Structure of Human Acvr1 in Complex with FM010942A
  118. 5s7w: Xchem Group Deposition -- Crystal Structure of Human Acvr1 in Complex with HM000007H
  119. 5s7x: Xchem Group Deposition -- Crystal Structure of Human Acvr1 in Complex with FM000376D
  120. 5s7y: Xchem Group Deposition -- Crystal Structure of Human Acvr1 in Complex with FM010933A
  121. 5s7z: Xchem Group Deposition -- Crystal Structure of Human Acvr1 in Complex with NU074488B
  122. 5s80: Xchem Group Deposition -- Crystal Structure of Human Acvr1 in Complex with FM010946A
  123. 5s81: Xchem Group Deposition -- Crystal Structure of Human Acvr1 in Complex with FM010947A
  124. 5s82: Xchem Group Deposition -- Crystal Structure of Human Acvr1 in Complex with XS035128C
  125. 5s83: Xchem Group Deposition -- Crystal Structure of Human Acvr1 in Complex with FM010948A
  126. 5s84: Xchem Group Deposition -- Crystal Structure of Human Acvr1 in Complex with FM010949A
  127. 5s85: Xchem Group Deposition -- Crystal Structure of Human Acvr1 in Complex with FM000884C
  128. 5s86: Xchem Group Deposition -- Crystal Structure of Human Acvr1 in Complex with FM010952A
  129. 5s87: Xchem Group Deposition -- Crystal Structure of Human Acvr1 in Complex with FM010953A
  130. 5s88: Xchem Group Deposition -- Crystal Structure of Human Acvr1 in Complex with FM010954A
  131. 5s89: Xchem Group Deposition -- Crystal Structure of Human Acvr1 in Complex with FM010957A
  132. 5s8a: Xchem Group Deposition -- Crystal Structure of Human Acvr1 in Complex with NU074484B
  133. 5s8b: Xchem Group Deposition -- Crystal Structure of Human Acvr1 in Complex with FM010960A
  134. 5s9k: Xchem Group Deposition -- Crystal Structure of Human Acvr1 in Complex with FM010955A
  135. 7l0j: Structure of Amh Bound to Amhr2-ecd
  136. 6unp: Crystal Structure of The Kinase Domain of BMPR2-D485G
  137. 6unq: Kinase Domain of ALK2-K493A with Amppnp
  138. 6unr: Kinase Domain of ALK2-K492A/K493A with Amppnp
  139. 6uns: Kinase Domain of ALK2-K492A/K493A with Ldn-193189
© Copyright 2008-2009 by enzymes.me.uk